{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T23:18:07Z","timestamp":1787008687230,"version":"build-2736575974"},"reference-count":38,"publisher":"Oxford University Press (OUP)","issue":"8","license":[{"start":{"date-parts":[[2018,5,11]],"date-time":"2018-05-11T00:00:00Z","timestamp":1525996800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/journals\/pages\/open_access\/funder_policies\/chorus\/standard_publication_model"}],"funder":[{"DOI":"10.13039\/501100005407","name":"Food and Health Bureau","doi-asserted-by":"publisher","award":["CU-15-A6"],"award-info":[{"award-number":["CU-15-A6"]}],"id":[{"id":"10.13039\/501100005407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2018,7,30]]},"DOI":"10.1093\/ecco-jcc\/jjy057","type":"journal-article","created":{"date-parts":[[2018,5,9]],"date-time":"2018-05-09T07:38:29Z","timestamp":1525851509000},"page":"954-962","source":"Crossref","is-referenced-by-count":31,"title":["A Prospective Study to Monitor for Tuberculosis During Anti-tumour Necrosis Factor Therapy in Patients With Inflammatory Bowel Disease and Immune-mediated Inflammatory Diseases"],"prefix":"10.1093","volume":"12","author":[{"given":"Choon Kin","family":"Lee","sequence":"first","affiliation":[{"name":"Department of Medicine and Therapeutics, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunny H v","family":"Wong","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace","family":"Lui","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Division of Infectious Disease, Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Whitney","family":"Tang","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lai San","family":"Tam","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Division of Rheumatology, Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ip","sequence":"additional","affiliation":[{"name":"Department of Microbiology, Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Hung","sequence":"additional","affiliation":[{"name":"Department of Radiology, Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minhu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Gastroenterology and Hepatology, First Affliated Hospital, Sun Yat-Sen University, Guangzhou, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin C","family":"Wu","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siew C","family":"Ng","sequence":"additional","affiliation":[{"name":"Department of Medicine and Therapeutics, Institute of Digestive Disease, Chinese University of Hong Kong, Hong Kong, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2018,5,11]]},"reference":[{"key":"key\n\t\t\t\t20180730065939_CIT0001","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1016\/S0140-6736(02)08512-4","article-title":"Maintenance infliximab for Crohn\u2019s disease: the ACCENT I randomised trial","volume":"359","author":"Hanauer","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180730065939_CIT0002","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1016\/S0140-6736(02)08215-6","article-title":"Treatment of active ankylosing spondylitis with infliximab: a randomised controlled multicentre trial","volume":"359","author":"Braun","year":"2002","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180730065939_CIT0003","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1002\/art.23721","article-title":"American College of Rheumatology 2008 recommendations for the use of nonbiologic and biologic disease-modifying antirheumatic drugs in rheumatoid arthritis","volume":"59","author":"Saag","year":"2008","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180730065939_CIT0004","first-page":"889","article-title":"Update on latent tuberculosis infection","volume":"89","author":"Hartman-Adams","year":"2014","journal-title":"Am Fam Physician"},{"key":"key\n\t\t\t\t20180730065939_CIT0005","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1056\/NEJMoa011110","article-title":"Tuberculosis associated with infliximab, a tumor necrosis factor alpha-neutralizing agent","volume":"345","author":"Keane","year":"2001","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180730065939_CIT0006","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1053\/j.gastro.2006.11.041","article-title":"Adalimumab for maintenance of clinical response and remission in patients with Crohn\u2019s disease: the CHARM trial","volume":"132","author":"Colombel","year":"2007","journal-title":"Gastroenterology"},{"key":"key\n\t\t\t\t20180730065939_CIT0007","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1056\/NEJMoa062897","article-title":"Maintenance therapy with certolizumab pegol for Crohn\u2019s disease","volume":"357","author":"Schreiber","year":"2007","journal-title":"N Engl J Med"},{"key":"key\n\t\t\t\t20180730065939_CIT0008","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.jbspin.2005.10.004","article-title":"The RATIO observatory: French registry of opportunistic infections, severe bacterial infections, and lymphomas complicating anti-TnF alpha therapy","volume":"72","author":"Tubach","year":"2005","journal-title":"Joint Bone Spine"},{"key":"key\n\t\t\t\t20180730065939_CIT0009","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1136\/ard.2009.118935","article-title":"Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register [BSRBR]","volume":"69","author":"Dixon","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180730065939_CIT0010","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1136\/gut.2008.175950","article-title":"The European [ECCO] Consensus on infection in IBD: what does it change for the clinician","volume":"58","author":"Rahier","year":"2009","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180730065939_CIT0011","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.crohns.2009.02.010","article-title":"European evidence-based consensus on the prevention, diagnosis and management of opportunistic infections in inflammatory bowel disease","volume":"3","author":"Rahier","year":"2009","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20180730065939_CIT0012","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1002\/art.21043","article-title":"Effectiveness of recommendations to prevent reactivation of latent tuberculosis infection in patients treated with tumor necrosis factor antagonists","volume":"52","author":"Carmona","year":"2005","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180730065939_CIT0013","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/art.20009","article-title":"Tuberculosis infection in patients with rheumatoid arthritis and the effect of infliximab therapy","volume":"50","author":"Wolfe","year":"2004","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180730065939_CIT0014","doi-asserted-by":"crossref","first-page":"419","DOI":"10.7326\/M14-1019","article-title":"Treatment of latent tuberculosis infection: a network meta-analysis","volume":"161","author":"Stagg","year":"2014","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180730065939_CIT0015","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1183\/09031936.00025510","article-title":"Discordance between TSTs and IFN-gamma release assays: the role of NTM and the relevance of mycobacterial sensitins","volume":"36","author":"Tebruegge","year":"2010","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20180730065939_CIT0016","volume-title":"Annual Report 2010 Tuberculosis and Chest Service","author":"Hong Kong Department of Health","year":"2011"},{"key":"key\n\t\t\t\t20180730065939_CIT0017","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1186\/1471-2334-9-207","article-title":"Performance of the tuberculin skin test and interferon-gamma release assay for detection of tuberculosis infection in immunocompromised patients in a BCG-vaccinated population","volume":"9","author":"Kim","year":"2009","journal-title":"BMC Infect Dis"},{"key":"key\n\t\t\t\t20180730065939_CIT0018","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1183\/09031936.06.00110205","article-title":"Use of a T-cell-based test for detection of tuberculosis infection among immunocompromised patients","volume":"28","author":"Piana","year":"2006","journal-title":"Eur Respir J"},{"key":"key\n\t\t\t\t20180730065939_CIT0019","doi-asserted-by":"crossref","first-page":"1610","DOI":"10.1136\/ard.2007.069799","article-title":"Comparison of in vitro-specific blood tests with tuberculin skin test for diagnosis of latent tuberculosis before anti-TNF therapy","volume":"66","author":"Sellam","year":"2007","journal-title":"Ann Rheum Dis"},{"key":"key\n\t\t\t\t20180730065939_CIT0020","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1002\/art.22768","article-title":"Risk of tuberculosis in patients treated with tumor necrosis factor antagonists due to incomplete prevention of reactivation of latent infection","volume":"57","author":"G\u00f3mez-Reino","year":"2007","journal-title":"Arthritis Rheum"},{"key":"key\n\t\t\t\t20180730065939_CIT0021","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S1473-3099(04)01206-X","article-title":"Interferon-gamma assays in the immunodiagnosis of tuberculosis: a systematic review","volume":"4","author":"Pai","year":"2004","journal-title":"Lancet Infect Dis"},{"key":"key\n\t\t\t\t20180730065939_CIT0022","doi-asserted-by":"crossref","first-page":"177","DOI":"10.7326\/0003-4819-149-3-200808050-00241","article-title":"Systematic review: T-cell-based assays for the diagnosis of latent tuberculosis infection: an update","volume":"149","author":"Pai","year":"2008","journal-title":"Ann Intern Med"},{"key":"key\n\t\t\t\t20180730065939_CIT0023","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1097\/MIB.0000000000000147","article-title":"Performance of interferon-gamma release assay for tuberculosis screening in inflammatory bowel disease patients","volume":"20","author":"Wong","year":"2014","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180730065939_CIT0024","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.1002\/ibd.22901","article-title":"Performance of interferon-gamma release assays in patients with inflammatory bowel disease: a systematic review and meta-analysis","volume":"18","author":"Shahidi","year":"2012","journal-title":"Inflamm Bowel Dis"},{"key":"key\n\t\t\t\t20180730065939_CIT0025","doi-asserted-by":"crossref","first-page":"271","DOI":"10.3343\/kjlm.2011.31.4.271","article-title":"Serial interferon-gamma release assays for the diagnosis of latent tuberculosis infection in patients treated with immunosuppressive agents","volume":"31","author":"Kim","year":"2011","journal-title":"Korean J Lab Med"},{"key":"key\n\t\t\t\t20180730065939_CIT0026","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/apt.12037","article-title":"Retesting for latent tuberculosis in patients with inflammatory bowel disease treated with TNF-\u03b1 inhibitors","volume":"36","author":"Papay","year":"2012","journal-title":"Aliment Pharmacol Ther"},{"key":"key\n\t\t\t\t20180730065939_CIT0027","doi-asserted-by":"crossref","first-page":"2769","DOI":"10.1016\/S0140-6736(17)32448-0","article-title":"Worldwide incidence and prevalence of inflammatory bowel disease in the 21st century: a systematic review of population-based studies","volume":"390","author":"Ng","year":"2018","journal-title":"Lancet"},{"key":"key\n\t\t\t\t20180730065939_CIT0028","volume-title":"Guidelines on Targeted Tuberculin Testing and Treatment of Latent Tuberculosis Infection","author":"Tuberculosis & Chest Service of the Department of Health of the Government of Hong Kong SAR","year":"2015"},{"key":"key\n\t\t\t\t20180730065939_CIT0029","first-page":"1","article-title":"Targeted tuberculin testing and treatment of latent tuberculosis infection. American Thoracic Society","volume":"49","author":"Cohn","year":"2000","journal-title":"MMWR Recomm Rep"},{"key":"key\n\t\t\t\t20180730065939_CIT0030","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1378\/chest.38.1.51","article-title":"Reversion and reconversion rate of tuberculin skin reactions in correction with the use of prednisone","volume":"38","author":"Bovornkitti","year":"1960","journal-title":"Dis Chest"},{"key":"key\n\t\t\t\t20180730065939_CIT0031","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.crohns.2012.05.012","article-title":"Risk of developing tuberculosis under anti-TNF treatment despite latent infection screening","volume":"7","author":"Jauregui-Amezaga","year":"2013","journal-title":"J Crohns Colitis"},{"key":"key\n\t\t\t\t20180730065939_CIT0032","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1164\/ajrccm.149.6.8004319","article-title":"Boosting of tuberculin sensitivity among Southeast Asian refugees","volume":"149","author":"Cauthen","year":"1994","journal-title":"Am J Respir Crit Care Med"},{"key":"key\n\t\t\t\t20180730065939_CIT0033","first-page":"28","article-title":"Controlled chemoprophylaxis trials in tuberculosis. A general review","volume":"26","author":"Ferebee","year":"1970","journal-title":"Bibl Tuberc"},{"key":"key\n\t\t\t\t20180730065939_CIT0034","first-page":"587","article-title":"The booster phenomenon in serial tuberculin testing","volume":"119","author":"Thompson","year":"1979","journal-title":"Am Rev Respir Dis"},{"key":"key\n\t\t\t\t20180730065939_CIT0035","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1016\/j.tube.2015.07.002","article-title":"Interferon gamma release assays for monitoring the response to treatment for tuberculosis: a systematic review","volume":"95","author":"Clifford","year":"2015","journal-title":"Tuberculosis [Edinb]"},{"key":"key\n\t\t\t\t20180730065939_CIT0036","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/S2213-2600(17)30060-7","article-title":"Serial QuantiFERON testing and tuberculosis disease risk among young children: an observational cohort study","volume":"5","author":"Andrews","year":"2017","journal-title":"Lancet Respir Med"},{"key":"key\n\t\t\t\t20180730065939_CIT0037","doi-asserted-by":"crossref","first-page":"A77","DOI":"10.1136\/gutjnl-2016-312388.137","article-title":"Ptu-050 addressing the issue of indeterminate interferon gamma release assays prior to biologic therapy in patients with inflammatory bowel disease patients","volume":"65","author":"Thi","year":"2016","journal-title":"Gut"},{"key":"key\n\t\t\t\t20180730065939_CIT0038","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1093\/ibd\/izx019","article-title":"Indeterminate QuantiFERON-TB gold increases likelihood of inflammatory bowel disease treatment delay and hospitalization","volume":"24","author":"Vajravelu","year":"2017","journal-title":"Inflamm Bowel Dis"}],"container-title":["Journal of Crohn's and Colitis"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/academic.oup.com\/ecco-jcc\/article-pdf\/12\/8\/954\/25177505\/jjy057.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,10,17]],"date-time":"2019-10-17T15:54:16Z","timestamp":1571327656000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ecco-jcc\/article\/12\/8\/954\/4994967"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,5,11]]},"references-count":38,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2018,5,11]]},"published-print":{"date-parts":[[2018,7,30]]}},"URL":"https:\/\/doi.org\/10.1093\/ecco-jcc\/jjy057","relation":{},"ISSN":["1873-9946","1876-4479"],"issn-type":[{"value":"1873-9946","type":"print"},{"value":"1876-4479","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2018,8]]},"published":{"date-parts":[[2018,5,11]]}}}